MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C Recall
MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C
FDA recall Class II
Ongoing
FDA lists this Class II recall for MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-0886-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Oct 27, 2025
- FDA report date
- Dec 17, 2025
- Quantity in commerce
- 15 units
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C
Affected model & UDI checker
Search the exact identifiers published for Z-0886-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| DYNJ39223C | MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C | Check source notice | Not specified |
| Not specified | MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C | Check source notice | 10193489621532 |
| Not specified | MEDLINE PERFUSION SYRINGE, REF: DYNJ39223C | Check source notice | 40193489621533 |
FDA code information
UDI/DI 10193489621532 (each) 40193489621533 (case), Lot Number 25FMJ081
Why was this product recalled?
Medline Industries, LP is issuing a recall for specific item(s) and lot(s) of Medline Kits containing BD Luer Tip Caps. BD has issued a recall of their Luer Tip Caps after confirming through internal testing that certain BD Luer Tip Cap trays failed routine biocompatibility testing. Although the tip cap covers a small surface area of the syringe and does not come in direct contact with patients, there is the potential that the failure of a biocompatibility test may have varying consequences ranging from no harm or clinical impact to potential for sensitization, irritation, pyrogenicity, acute systemic toxicity or hemolysis depending on the nature and duration of contact with the syringe.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Medline Industries, LP take?
Medline Industries issued an URGENT MEDICAL DEVICE RECALL to its consignee on 10/27/2025 via email. The notice explained the issue, potential risk, and requested the affected product be quarantined. Once the firm receives the response form, Medline will provide over-labels which are to be placed on kits that contain the recalled component and will state the affected component shall be removed and discarded from further use. Distributors and those further distributing the affected product are directed to notify those to whom the product was transferred or distributed of the recall. For questions, contact the Recall Department at 866-359-1704 or [email protected].
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-0886-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 21, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 21, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology